Absorption |
Blood-Brain Barrier | BBB- | 0.5633 |
Human Intestinal Absorption | HIA+ | 0.8530 |
Caco-2 Permeability | Caco2- | 0.6529 |
P-glycoprotein Substrate | Substrate | 0.9040 |
P-glycoprotein Inhibitor | Inhibitor | 0.7478 |
Non-inhibitor | 0.7130 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6838 |
Distribution |
Subcellular localization | Mitochondria | 0.7933 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6845 |
CYP450 2D6 Substrate | Non-substrate | 0.5889 |
CYP450 3A4 Substrate | Non-substrate | 0.6688 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5747 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8370 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5603 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8180 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.5752 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6580 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9105 |
Inhibitor | 0.5517 |
AMES Toxicity | Non AMES toxic | 0.7820 |
Carcinogens | Non-carcinogens | 0.9077 |
Fish Toxicity | High FHMT | 0.9215 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9204 |
Honey Bee Toxicity | Low HBT | 0.7907 |
Biodegradation | Not ready biodegradable | 0.9902 |
Acute Oral Toxicity | III | 0.5370 |
Carcinogenicity (Three-class) | Non-required | 0.6684 |